← Back to Clinical Trials
Recruiting NCT07923695

NCT07923695 Probiotics Versus Antibiotics as an Adjuvant to Non-surgical Periodontal Treatment Among Smokers With Stage II, Grade B Periodontitis

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07923695
Status Recruiting
Phase —
Sponsor October 6 University
Condition Probiotics
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2024-09-01
Primary Completion 2027-06-01

Eligibility & Interventions

Sex All sexes
Min Age 25 Years
Max Age 50 Years
Study Type INTERVENTIONAL
Interventions
VitacareVibramycin + FasigynNon-surgical treatment modality

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 30 participants in total. It began in 2024-09-01 with a primary completion date of 2027-06-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of the present study is to evaluate and compare the clinical and biochemical effectiveness of systemic probiotics versus systemic antibiotics when used as adjuncts to nonsurgical periodontal treatment, scaling and root planing (SRP) in adult smoker patients diagnosed with Stage II, Grade B periodontitis

Eligibility Criteria

Inclusion Criteria: * Age 25-50 years * Periodontitis male patients diagnosed as they having Stage II, Grade B periodontitis * Clinical attachment loss 3-4 mm * Radiographic bone loss in coronal third. * Current smokers or non-smokers. Exclusion Criteria: * Systemic diseases affecting periodontal health. * Periodontal therapy within last 6 months. * Use of antibiotics, probiotics or anti-inflammatory medication within last 3 months. * History of allergy to the prescribed study medications. * Patients unwilling to comply with study instructions or follow-up visits

Contact & Investigator

Central Contact

Ahlam A Al-shawafi, B.Sc

✉ Periodentistahlam@gmail.com

📞 00201156330099

Frequently Asked Questions

Who can join the NCT07923695 clinical trial?

This trial is open to participants of all sexes, aged 25 Years or older, up to 50 Years, studying Probiotics. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07923695 currently recruiting?

Yes, NCT07923695 is actively recruiting participants. Contact the research team at Periodentistahlam@gmail.com for enrollment information.

Where is the NCT07923695 trial being conducted?

This trial is being conducted at Cairo, Egypt.

Who is sponsoring the NCT07923695 clinical trial?

NCT07923695 is sponsored by October 6 University. The trial plans to enroll 30 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology